SG Americas Securities, LLC - ORAMED PHARMACEUTICALS INC ownership

ORAMED PHARMACEUTICALS INC's ticker is ORMP and the CUSIP is 68403P203. A total of 57 filers reported holding ORAMED PHARMACEUTICALS INC in Q3 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.0%.

Quarter-by-quarter ownership
SG Americas Securities, LLC ownership history of ORAMED PHARMACEUTICALS INC
ValueSharesWeighting
Q4 2022$125
-99.8%
10,3700.0%0.00%
+100.0%
Q3 2022$67,000
-68.5%
10,370
-77.7%
0.00%
-50.0%
Q2 2022$213,000
+73.2%
46,532
+439.1%
0.00%
+100.0%
Q4 2021$123,000
-58.7%
8,631
-36.3%
0.00%0.0%
Q3 2021$298,00013,5410.00%
Other shareholders
ORAMED PHARMACEUTICALS INC shareholders Q3 2023
NameSharesValueWeighting ↓
Acrospire Investment Management LLC 8,355$61,0000.04%
TOCQUEVILLE ASSET MANAGEMENT L.P. 70,000$508,0000.01%
Financial Architects, Inc 2,000$15,0000.00%
FineMark National Bank & Trust 3,473$25,0000.00%
JFS WEALTH ADVISORS, LLC 1,000$7,0000.00%
Penserra Capital Management LLC 2,540$18,0000.00%
Tower Research Capital LLC (TRC) 1,284$10,0000.00%
SIMPLEX TRADING, LLC 2,673$19,0000.00%
Plante Moran Financial Advisors, LLC 300$2,0000.00%
Cutler Group LLC / CA 2,404$17,0000.00%
View complete list of ORAMED PHARMACEUTICALS INC shareholders